Last reviewed · How we verify

NCT04221685

Intraoperative Pain After Infiltration Technique Using Artpharma Versus Artinibsa in Children

Status unknown NA Last updated 8 October 2020
What this trial tests

NA trial testing Artpharma in Pain, Postoperative in 130 participants. Status unknown.

Timeline
1 December 2020
Primary endpoint
1 December 2021
1 December 2021

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment130
Start date1 December 2020
Primary completion1 December 2021
Estimated completion1 December 2021

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 6 to 9, any sex, with Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess Intraoperative pain for extraction of Maxillary primary molars using Artpharma Versus Artinibsa in children during infiltration technique.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Artpharma

Trials testing the same drug.

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04221685.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing